Showing 37 to 48 of 99 results
Guildford Prostate Cancer Screening Pilot Underscores Need for National Program
A successful prostate cancer screening pilot program in Guildford, UK, detected hundreds of previously unknown cases in high-risk men aged 50-70, highlighting the need for a national program supported by 94% of GPs and the Health Secretary, to address the current 45% of diagnoses made after the dise...
Guildford Prostate Cancer Screening Pilot Underscores Need for National Program
A successful prostate cancer screening pilot program in Guildford, UK, detected hundreds of previously unknown cases in high-risk men aged 50-70, highlighting the need for a national program supported by 94% of GPs and the Health Secretary, to address the current 45% of diagnoses made after the dise...
Progress
56% Bias Score
Saliva Test Shows Improved Accuracy in Prostate Cancer Risk Assessment
A new saliva test shows promise in identifying prostate cancer risk more accurately than the standard PSA blood test, with 40% of high-risk men in a UK study having cancer, compared to 25% with the PSA test, potentially reducing unnecessary biopsies.
Saliva Test Shows Improved Accuracy in Prostate Cancer Risk Assessment
A new saliva test shows promise in identifying prostate cancer risk more accurately than the standard PSA blood test, with 40% of high-risk men in a UK study having cancer, compared to 25% with the PSA test, potentially reducing unnecessary biopsies.
Progress
40% Bias Score
Colorectal Cancer Awareness: Rising Rates and Prevention Strategies
Colorectal cancer is the third leading cause of cancer death in US men and fourth in women; over 150,000 cases are expected this year, with 52,900 deaths; March is Colorectal Cancer Awareness Month; risk factors include obesity, diabetes, smoking, alcohol, diet, genetics, and family history; screeni...
Colorectal Cancer Awareness: Rising Rates and Prevention Strategies
Colorectal cancer is the third leading cause of cancer death in US men and fourth in women; over 150,000 cases are expected this year, with 52,900 deaths; March is Colorectal Cancer Awareness Month; risk factors include obesity, diabetes, smoking, alcohol, diet, genetics, and family history; screeni...
Progress
16% Bias Score
New Blood Test Shows Promise for Early Pancreatic Cancer Detection
Researchers in Zurich and Portland have developed a blood test that detects pancreatic cancer in early stages with 73% accuracy, offering hope against this deadly disease with a historically low survival rate due to late diagnosis.
New Blood Test Shows Promise for Early Pancreatic Cancer Detection
Researchers in Zurich and Portland have developed a blood test that detects pancreatic cancer in early stages with 73% accuracy, offering hope against this deadly disease with a historically low survival rate due to late diagnosis.
Progress
32% Bias Score
Colorectal Cancer Deaths in Germany Decrease by 17 Percent
Germany saw a 17 percent decrease in colorectal cancer deaths between 2003 and 2023 (28,900 to 24,100), alongside a 30 percent drop in hospitalizations (to 139,200 in 2023), possibly due to improved treatments and early detection; however, overall cancer deaths increased by 10 percent.
Colorectal Cancer Deaths in Germany Decrease by 17 Percent
Germany saw a 17 percent decrease in colorectal cancer deaths between 2003 and 2023 (28,900 to 24,100), alongside a 30 percent drop in hospitalizations (to 139,200 in 2023), possibly due to improved treatments and early detection; however, overall cancer deaths increased by 10 percent.
Progress
40% Bias Score
Five Speech Changes Indicating Early Onset Alzheimer's
Five early speech changes—hesitations, using wrong words, describing instead of doing, reduced vocabulary, and word-finding difficulties—can indicate Alzheimer's, impacting millions globally and highlighting the need for early detection, especially in high-risk groups like those with Down syndrome.
Five Speech Changes Indicating Early Onset Alzheimer's
Five early speech changes—hesitations, using wrong words, describing instead of doing, reduced vocabulary, and word-finding difficulties—can indicate Alzheimer's, impacting millions globally and highlighting the need for early detection, especially in high-risk groups like those with Down syndrome.
Progress
12% Bias Score
Corporate Partnerships Drive 34% Drop in Cancer Death Rate
The American Cancer Society's collaborative efforts with Genentech, Pfizer, and Merck have resulted in a 34% decrease in the cancer death rate since 1991, averting an estimated 4.5 million deaths, through expanded cancer screening and targeted initiatives addressing healthcare inequities.
Corporate Partnerships Drive 34% Drop in Cancer Death Rate
The American Cancer Society's collaborative efforts with Genentech, Pfizer, and Merck have resulted in a 34% decrease in the cancer death rate since 1991, averting an estimated 4.5 million deaths, through expanded cancer screening and targeted initiatives addressing healthcare inequities.
Progress
44% Bias Score
Seymour Tops List of Victorian Bowel Cancer Hotspots
Analysis of 2010-2019 data reveals Seymour, Victoria, as a bowel cancer hotspot, with rates 28% above the Australian average; this regional concentration contrasts with lower rates in Melbourne's inner city, highlighting the need for further investigation into regional risk factors.
Seymour Tops List of Victorian Bowel Cancer Hotspots
Analysis of 2010-2019 data reveals Seymour, Victoria, as a bowel cancer hotspot, with rates 28% above the Australian average; this regional concentration contrasts with lower rates in Melbourne's inner city, highlighting the need for further investigation into regional risk factors.
Progress
36% Bias Score
Fecal Tests as Effective as Colonoscopy in Reducing Colorectal Cancer Mortality
A Spanish study of 57,000 people aged 50-69 found fecal blood tests as effective as colonoscopy in reducing colorectal cancer mortality, despite lower colonoscopy participation (31.8% vs 40%).
Fecal Tests as Effective as Colonoscopy in Reducing Colorectal Cancer Mortality
A Spanish study of 57,000 people aged 50-69 found fecal blood tests as effective as colonoscopy in reducing colorectal cancer mortality, despite lower colonoscopy participation (31.8% vs 40%).
Progress
32% Bias Score
Colorectal Cancer Deaths in Germany Decline by 17 Percent in Two Decades
Germany saw a 17 percent decrease in colorectal cancer deaths between 2003 and 2023, dropping from 28,900 to 24,100, while hospitalizations decreased by 30 percent, attributed to improved treatment and early detection programs.
Colorectal Cancer Deaths in Germany Decline by 17 Percent in Two Decades
Germany saw a 17 percent decrease in colorectal cancer deaths between 2003 and 2023, dropping from 28,900 to 24,100, while hospitalizations decreased by 30 percent, attributed to improved treatment and early detection programs.
Progress
24% Bias Score
Accidental Discovery of Thyroid Cancer in 19-Year-Old Highlights Importance of Comprehensive Medical Checkups
A 19-year-old Rostov resident's visit to an endocrinologist for weight issues unexpectedly revealed thyroid cancer in both lobes, highlighting the importance of comprehensive medical examinations and early detection.
Accidental Discovery of Thyroid Cancer in 19-Year-Old Highlights Importance of Comprehensive Medical Checkups
A 19-year-old Rostov resident's visit to an endocrinologist for weight issues unexpectedly revealed thyroid cancer in both lobes, highlighting the importance of comprehensive medical examinations and early detection.
Progress
32% Bias Score
Sarah Harding-Inspired Study Identifies 88 Young Women at Increased Breast Cancer Risk
The BCAN-RAY study, inspired by Sarah Harding, has identified 88 young women at increased breast cancer risk, highlighting a critical need for earlier screening and intervention among younger women in the UK, currently lacking in national protocols that begin at age 50.
Sarah Harding-Inspired Study Identifies 88 Young Women at Increased Breast Cancer Risk
The BCAN-RAY study, inspired by Sarah Harding, has identified 88 young women at increased breast cancer risk, highlighting a critical need for earlier screening and intervention among younger women in the UK, currently lacking in national protocols that begin at age 50.
Progress
40% Bias Score
Showing 37 to 48 of 99 results